Alternative splicing in cancers: From aberrant regulation to new therapeutics.

Song, Xiaowei; Zeng, Zhenyu; Wei, Huanhuan; Wang, Zefeng

Song, Xiaowei; Zeng, Zhenyu; Wei, Huanhuan; Wang, Zefeng.

Afiliação

Song X; CAS Key Lab for Computational Biology, CAS Center for Excellence in Molecular Cell Science, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China; Department of Cardiology, Changhai Hospital, 168 Changhai
Zeng Z; Department of Cardiology, Changhai Hospital, 168 Changhai Road, Shanghai 200433, China.
Wei H; CAS Key Lab for Computational Biology, CAS Center for Excellence in Molecular Cell Science, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
Wang Z; CAS Key Lab for Computational Biology, CAS Center for Excellence in Molecular Cell Science, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China. Electronic address: wangzefeng@picb.ac.cn.

Semin Cell Dev Biol ; 75: 13-22, 2018 03.

Article em En | MEDLINE | ID: mdl-28919308

Assuntos

Processamento Alternativo; Carcinogênese/genética; Regulação Neoplásica da Expressão Gênica; Neoplasias/genética; Animais; Humanos; Modelos Genéticos; Neoplasias/terapia; RNA/genética; RNA Circular; RNA Longo não Codificante/genética; Spliceossomos/genética

Palavras-chave

Alternative splicing; Cancer; Engineered splicing factors; RNA-binding protein

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Processamento Alternativo / Carcinogênese / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google